INTECH Investment Management’s Vir Biotechnology VIR Stock Holding History

INTECH Investment Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Buy	68,270 +6,545	+11%	+$62.3K	0.01%	1191
2026 Q1	$553K	Buy	61,725 +25,421	+70%	+$203K	0.01%	1292
2025 Q4	$219K	Sell	36,304 -4,422	-11%	-$26.3K	﹤0.01%	1935
2025 Q3	$233K	Sell	40,726 -8,273	-17%	-$42.3K	﹤0.01%	1980
2025 Q2	$247K	Sell	48,999 -13,642	-22%	-$73.1K	﹤0.01%	1984
2025 Q1	$406K	Buy	62,641 +25,633	+69%	+$228K	﹤0.01%	1725
2024 Q4	$272K	Buy	37,008 +11,486	+45%	+$90.6K	﹤0.01%	1880
2024 Q3	$191K	Buy	+25,522	New	+$222K	﹤0.01%	1744

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

INTECH Investment Management's VIR Position: Q2 2026 in Review

INTECH Investment Management increased its Vir Biotechnology (VIR) stake by 11% in Q2 2026, buying an estimated $62.3K and bringing the position to 68,270 shares worth $696K. The position accounts for 0.01% of the portfolio, ranked #1191.

INTECH Investment Management first reported a position in VIR in Q3 2024 and has held it in 8 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

INTECH Investment Management held 68,270 shares of Vir Biotechnology worth $696K as of Q2 2026.
INTECH Investment Management bought 6,545 Vir Biotechnology shares in Q2 2026, an estimated $62.3K.
Vir Biotechnology made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1191 holding.
INTECH Investment Management first reported a position in Vir Biotechnology in Q3 2024 and has held it in 8 quarters since.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.